Stock Scorecard
Stock Summary for Tandem Diabetes Care Inc (TNDM) - $12.43 as of 9/16/2025 9:21:28 PM EST
Total Score
8 out of 30
Safety Score
36 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for TNDM
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for TNDM
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for TNDM
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for TNDM
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for TNDM (36 out of 100)
| Stock Price Rating (Max of 10) | 5 |
| Historical Stock Price Rating (Max of 10) | 10 |
| Stock Price Trend (Max of 10) | 1 |
| Book Value (Max of 10) | 2 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 9 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for TNDM
Financial Details for TNDM
Company Overview |
|
|---|---|
| Ticker | TNDM |
| Company Name | Tandem Diabetes Care Inc |
| Country | USA |
| Description | Tandem Diabetes Care, Inc., a medical device company, designs, develops, and markets various products for people with insulin-dependent diabetes in the United States. The company is headquartered in San Diego, California. |
| Sector Name | HEALTHCARE |
| Industry Name | MEDICAL DEVICES |
| Most Recent Quarter | 6/30/2025 |
| Next Earnings Date | 10/29/2025 |
Stock Price History |
|
| Last Day Price | 12.43 |
| Price 4 Years Ago | 150.52 |
| Last Day Price Updated | 9/16/2025 9:21:28 PM EST |
| Last Day Volume | 1,849,102 |
| Average Daily Volume | 2,467,754 |
| 52-Week High | 47.60 |
| 52-Week Low | 9.98 |
| Last Price to 52 Week Low | 24.55% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 44.54 |
| Sector PE | 40.64 |
| 5-Year Average PE | 12.64 |
| Free Cash Flow Ratio | 13.08 |
| Industry Free Cash Flow Ratio | 38.93 |
| Sector Free Cash Flow Ratio | 29.51 |
| Current Ratio Most Recent Quarter | 2.44 |
| Total Cash Per Share | 0.95 |
| Book Value Per Share Most Recent Quarter | 1.97 |
| Price to Book Ratio | 6.22 |
| Industry Price to Book Ratio | 3.88 |
| Sector Price to Book Ratio | 32.14 |
| Price to Sales Ratio Twelve Trailing Months | 0.83 |
| Industry Price to Sales Ratio Twelve Trailing Months | 4.41 |
| Sector Price to Sales Ratio Twelve Trailing Months | 19.15 |
| Analyst Buy Ratings | 6 |
| Analyst Strong Buy Ratings | 3 |
Share Statistics |
|
| Total Shares Outstanding | 67,570,000 |
| Market Capitalization | 839,895,100 |
| Institutional Ownership | 120.63% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | -37.00% |
| Annual Earnings Growth | 56.86% |
| Reported EPS 12 Trailing Months | -3.08 |
| Reported EPS Past Year | -1.45 |
| Reported EPS Prior Year | -1.90 |
| Net Income Twelve Trailing Months | -205,452,000 |
| Net Income Past Year | -96,025,000 |
| Net Income Prior Year | -222,611,000 |
| Quarterly Revenue Growth YOY | 8.50% |
| 5-Year Revenue Growth | 21.01% |
| Operating Margin Twelve Trailing Months | -13.20% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 64,112,000 |
| Total Cash Past Year | 69,234,000 |
| Total Cash Prior Year | 58,868,000 |
| Net Cash Position Most Recent Quarter | -245,034,000 |
| Net Cash Position Past Year | -239,032,000 |
| Long Term Debt Past Year | 308,266,000 |
| Long Term Debt Prior Year | 285,035,000 |
| Total Debt Most Recent Quarter | 309,146,000 |
| Equity to Debt Ratio Past Year | 0.46 |
| Equity to Debt Ratio Most Recent Quarter | 0.30 |
| Total Stockholder Equity Past Year | 263,098,000 |
| Total Stockholder Equity Prior Year | 313,632,000 |
| Total Stockholder Equity Most Recent Quarter | 133,283,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -54,161,000 |
| Free Cash Flow Per Share Twelve Trailing Months | -0.80 |
| Free Cash Flow Past Year | 4,994,000 |
| Free Cash Flow Prior Year | -83,413,000 |
Options |
|
| Put/Call Ratio | 0.25 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.33 |
| MACD Signal | -0.58 |
| 20-Day Bollinger Lower Band | 8.92 |
| 20-Day Bollinger Middle Band | 16.95 |
| 20-Day Bollinger Upper Band | 24.99 |
| Beta | 1.46 |
| RSI | 46.72 |
| 50-Day SMA | 25.02 |
| 150-Day SMA | 31.12 |
| 200-Day SMA | 45.89 |
System |
|
| Modified | 9/16/2025 11:28:35 AM EST |